Basis of the first Palestinian trauma registry: a multicentre retrospective chart review from the West Bank

• by Peter Bael, Zakaria Abu Ghattas, Adam Albedd, Sandra Istefan, Malik Itmaiza, Bayan Alqtishat, Nizar Qumsieh, Tawfeeq Al-Shobaki, Hussein Hallak

• September 1, 2026

Perspectives on Medicare’s Proposed iDose TR Coverage Policy

In May 2026, 5 Medicare Administrative Contractors released proposed Local Coverage Determinations (LCDs) addressing Medicare reimbursement for anterior-segment intraocular nonbiodegradable drug-eluting systems, a category that currently includes only the travoprost intracameral implant iDose TR (Glaukos). Many glaucoma specialists believe the proposed LCDs do not reflect contemporary glaucoma practice or the clinical rationale underlying sustained drug-delivery therapies. Glaucoma Physician spoke with several leading surgeons about the proposed LCDs, the reasons for their concerns, and the changes they believe would better reflect contemporary glaucoma practice.

• by Steven R. Sarkisian, Jr., MD, Inder Paul Singh, MD, Savak “Sev” Teymoorian, MD, MBA, Manjool Shah, MD, Christine Funke, MD, Philip S. Garza, MD, MSc

• September 1, 2026

• 10 min

Do antihistamines help atopic dermatitis?

First-generation H1 antihistamines likely increase cognitive impairment, with cognitive effects differing among second-generation antihistamines.

• by Kathryn Wighton

• August 31, 2026

• 4 min

The Scleral Lens Vault: <br>Observing Your Fluorescein</br>

In the times of ever-advancing new technology for precise fitting of scleral lenses, has the art of diagnostic fitting fallen to the wayside

• by Jamie Kuzniar, OD

• September 1, 2026

• 4 min